Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)
Agrupación estratéxica de I+D+i
![Foto de Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)](/img/noimage.png)
![Foto de Hospital Vall d'Hebron](/img/noimage_org.png)
Hospital Vall d'Hebron
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (52)
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
HTLV-1-associated myelopathy in Spain
Journal of Clinical Virology, Vol. 169
-
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 3, pp. 128-132
-
The slowdown of new infections by human retroviruses has reached a plateau in Spain
Journal of Medical Virology, Vol. 95, Núm. 5
-
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021
Journal of Medical Virology, Vol. 95, Núm. 12
2022
-
Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation
Journal of experimental & clinical cancer research : CR, Vol. 41, Núm. 1, pp. 285
-
Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network
International Journal of Infectious Diseases, Vol. 122, pp. 970-975
2021
-
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study
Open Forum Infectious Diseases, Vol. 8, Núm. 6
2020
-
GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000–2016)
Journal of Infection, Vol. 81, Núm. 4, pp. 600-606
-
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations
The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 5, pp. 1294-1300
2019
-
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
-
HIV co-infection in HTLV-1 carriers in Spain
Virus Research, Vol. 266, pp. 48-51
2017
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
-
Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study)
Journal of Viral Hepatitis, Vol. 24, Núm. 9, pp. 725-732
2016
-
Urgent stroke care in hospitals with a stroke unit. Quick project
Revista de Neurologia, Vol. 62, Núm. 7, pp. 303-310
2015
-
Left-sided infective endocarditis in patients with liver cirrhosis
Journal of Infection, Vol. 71, Núm. 6, pp. 627-641
-
The burden of neglected HIV-2 and HTLV-1 infections in Spain
AIDS Reviews, Vol. 17, Núm. 4, pp. 212-219